However, interest in getting the vaccine has risen, with 71 percent of Americans now willing to be vaccinated
WEDNESDAY, Feb. 10, 2021 (HealthDay News) — As the United States enters a critical phase of its national coronavirus vaccination campaign, a new poll shows that two-thirds of Americans are frustrated with how hard it is to get immunized against COVID-19.
The Gallup Poll, released Wednesday morning, comes as health officials across the country are desperately juggling precious vaccine doses so they can put second shots into the arms of those who have had their first dose, while still getting first shots to eligible Americans.
In the poll, 66 percent of Americans were dissatisfied with the handling of the vaccine rollout, including 21 percent who were “very dissatisfied,” according to the survey of 4,098 adults conducted between Jan. 25 and Jan. 31. The effort, hampered by long lines and vaccine shortages, has frustrated many people eligible for immunization, including health care workers and seniors, as some have been unable to book appointments.
But a heartening sign also emerged: Despite the frustration, the same survey revealed an increase in interest to get the vaccine, with 71 percent of Americans now willing to be vaccinated, up from 65 percent in late December.
One of the most common reasons people gave for feeling reluctant was concern about the rushed timeline. Twenty-two percent said they want to wait for more people to get vaccinated to confirm it is safe. But 28 percent cited other reasons, including theories that concern about the virus is overblown or they already have antibodies because of previous COVID-19 infection.
While Americans in both political parties have increasingly expressed their willingness to get the vaccine, Democrats surveyed were far more likely to want to get vaccinated. Ninety-one percent of Democrats said they were willing to be immunized, and about 51 percent of Republicans said the same — the highest percentages to date for either group.
Copyright © 2020 HealthDay. All rights reserved.
